Literature DB >> 12677302

Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI.

J Meller1, F Strutz, U Siefker, A Scheel, C O Sahlmann, K Lehmann, M Conrad, R Vosshenrich.   

Abstract

The aim of this prospective study was to compare fluorine-18 fluorodeoxyglucose ([(18)F]FDG) positron emission tomography (PET) with magnetic resonance imaging (MRI) in patients with early aortitis, at the time of initial diagnosis and during immunosuppressive therapy. The study population consisted of 15 patients (nine females and six males; median age 62 years, range 26-76 years) who presented with fever of unknown origin or an elevated erythrocyte sedimentation rate or elevated C-reactive protein and who showed pathological aortic [(18)F]FDG uptake. Fourteen of these patients had features of early giant cell arteritis (GCA), while one had features of early Takayasu arteritis. During follow-up, seven PET scans were performed in six patients with GCA 4-30 months (median 19 months) after starting immunosuppressive medication. The results of [(18)F]FDG imaging were compared with the results of MRI at initial evaluation and during follow-up and with the clinical findings. At baseline, abnormal [(18)F]FDG uptake was present in 59/104 (56%) of the vascular regions studied in 15 patients. Seven follow-up PET studies were performed in six patients. Of 30 regions with initial pathological uptake in these patients, 24 (80%) showed normalisation of uptake during follow-up. Normalisation of [(18)F]FDG uptake correlated with clinical improvement and with normalisation of the laboratory findings. All except one of the patients with positive aortic [(18)F]FDG uptake were investigated with MRI and MRA. Thirteen of these 14 patients showed inflammation in at least one vascular region. Of 76 vascular regions studied, 41 (53%) showed vasculitis on MRI. Of 76 vascular regions studied with both PET and MRI, 47 were concordantly positive or negative on both modalities, 11 were positive on MRI only and 18 were positive on PET only. MRI was performed during follow-up in six patients: of 17 regions with inflammatory changes, 15 regions remained unchanged and two showed improvement. Whole-body [(18)F]FDG PET is valuable in the primary diagnosis of early aortitis. The results of [(18)F]FDG PET and MRI in the diagnosis of aortitis in this study were comparable, but FDG imaging identified more vascular regions involved in the inflammatory process than did MRI. In a limited number of patients [(18)F]FDG PET was more reliable than MRI in monitoring disease activity during immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12677302     DOI: 10.1007/s00259-003-1144-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  14 in total

Review 1.  Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors.

Authors:  M B Gravanis
Journal:  Int J Cardiol       Date:  2000-08-31       Impact factor: 4.164

2.  Accelerated image reconstruction using ordered subsets of projection data.

Authors:  H M Hudson; R S Larkin
Journal:  IEEE Trans Med Imaging       Date:  1994       Impact factor: 10.048

Review 3.  Takayasu arteritis: MR manifestations and diagnosis of acute and chronic phase.

Authors:  N Matsunaga; K Hayashi; I Sakamoto; Y Matsuoka; Y Ogawa; K Honjo; K Takano
Journal:  J Magn Reson Imaging       Date:  1998 Mar-Apr       Impact factor: 4.813

4.  Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET.

Authors:  J Meller; G Altenvoerde; U Munzel; A Jauho; M Behe; S Gratz; H Luig; W Becker
Journal:  Eur J Nucl Med       Date:  2000-11

5.  [An iterative strategy for determining the source distribution in single photon tomography using a rotating gamma camera (SPECT)].

Authors:  H Luig; W Eschner; M Bähre; E Voth; G Nolte
Journal:  Nuklearmedizin       Date:  1988-08       Impact factor: 1.379

Review 6.  Takayasu's arteritis.

Authors:  G S Kerr
Journal:  Rheum Dis Clin North Am       Date:  1995-11       Impact factor: 2.670

7.  Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis.

Authors:  A Turlakow; H W Yeung; J Pui; H Macapinlac; E Liebovitz; V Rusch; A Goy; S M Larson
Journal:  Arch Intern Med       Date:  2001-04-09

8.  New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography.

Authors:  D Blockmans; A Maes; S Stroobants; J Nuyts; G Bormans; D Knockaert; H Bobbaers; L Mortelmans
Journal:  Rheumatology (Oxford)       Date:  1999-05       Impact factor: 7.580

9.  Takayasu arteritis may be underdiagnosed in North America.

Authors:  B K Sharma; N Siveski-Iliskovic; P K Singal
Journal:  Can J Cardiol       Date:  1995-04       Impact factor: 5.223

10.  Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases.

Authors:  J M Evans; C A Bowles; J Bjornsson; C J Mullany; G G Hunder
Journal:  Arthritis Rheum       Date:  1994-10
View more
  97 in total

Review 1.  Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles.

Authors:  Ian S Rogers; Ahmed Tawakol
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

2.  The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis.

Authors:  Myles Webb; Anthony Chambers; Adil AL-Nahhas; Justin C Mason; Lucy Maudlin; Lucy Rahman; John Frank
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-17       Impact factor: 9.236

3.  Non-invasive imaging in the diagnosis and management of Takayasu's arteritis.

Authors:  J Andrews; A Al-Nahhas; D J Pennell; M S Hossain; K A Davies; D O Haskard; J C Mason
Journal:  Ann Rheum Dis       Date:  2004-08       Impact factor: 19.103

4.  The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis.

Authors:  Martin Fuchs; Matthias Briel; Thomas Daikeler; Ulrich A Walker; Helmut Rasch; Scott Berg; Quinn K T Ng; Heike Raatz; David Jayne; Ina Kötter; Daniel Blockmans; Maria C Cid; Sergio Prieto-González; Peter Lamprecht; Carlo Salvarani; Zaharenia Karageorgaki; Richard Watts; Raashid Luqmani; Jan Müller-Brand; Alan Tyndall; Martin A Walter
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

Review 5.  Aneurysmatic disease in patients with Takayasu disease: a case review.

Authors:  S Perrotta; G Rådberg; A Perrotta; S Lentini
Journal:  Herz       Date:  2011-11-11       Impact factor: 1.443

6.  Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: a multicenter retrospective study.

Authors:  G A Hooisma; H Balink; P M Houtman; R H J A Slart; K D F Lensen
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

Review 7.  Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review.

Authors:  Giorgio Treglia; Maria Vittoria Mattoli; Lucia Leccisotti; Gianfranco Ferraccioli; Alessandro Giordano
Journal:  Clin Rheumatol       Date:  2011-08-11       Impact factor: 2.980

8.  Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study.

Authors:  Ingo Einspieler; Klaus Thürmel; Thomas Pyka; Matthias Eiber; Sabine Wolfram; Philipp Moog; Christian Reeps; Markus Essler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-16       Impact factor: 9.236

9.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

Review 10.  [Imaging of aortic disease].

Authors:  P Reimer; R Vosshenrich; P Landwehr; M Storck
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.